Jazz Pharmaceuticals (JAZZ) Issues Long-Term Vision and Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/7/2026
- Wall St futures fall as yields and oil rebound; Fed minutes in focus
- Want to be a stock market bear? BCA says watch potential U.S. tax increases
- SpaceX seeks $40bn in financing for Nvidia chip purchase
- Musk rules out TSMC role in Terafab operations; Intel gains
- U.S. 10-year yield climb revives dotcom-era parallels: UBS weighs in
| JAZZ PHARMACEUTICAL (NASDAQ: JAZZ) | Delayed: 231.39 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $231.39 | 52 Week High | $160.00 | |||
| Open | $231.39 | 52 Week Low | $95.80 | |||
| Day High | $231.39 | P/E | 43.01 | |||
| Day Low | $231.39 | EPS | $5.38 | |||
| Volume | 1,133 | |||||
